METTL3, the key m6A methyltransferase, has been shown to regulate early embryonic development [11], neurogenesis [12], diabetes [13], and nonalcoholic steatohepatitis (NASH) [14]. The gene discussed is METTL3; the disease is metabolic dysfunction-associated steatohepatitis.